Literature DB >> 11589480

Saquinavir up-regulates telomerase activity in lymphocytes activated with monoclonal antibodies against CD3/CD28.

F A Comandini1, A Lombardi, A Saponiero, E Bonmassar.   

Abstract

The present study describes the effect of the HIV protease inhibitor saquinavir on telomerase activity and interferon-gamma (IFN-gamma) production of nonadherent mononuclear cells (NA-MNC). Cells obtained from peripheral blood of healthy donors were exposed in vitro to a mixture of monoclonal antibodies against CD3 and CD28 membrane antigens in order to activate prevalently T cell subsets. Treatment with saquinavir was performed at the time of cell stimulation. Thereafter, NA-MNC were tested for telomerase activity (TRAP assay) and interferon-gamma production up to 7 days later. The results show that saquinavir up-regulates telomerase activity and IFN-gamma release in activated NA-MNC. These observations suggest that the anti-HIV effects of saquinavir could be accompanied by other immunopharmacological properties, influencing some aspects of the functional activity of immunocompetent cells. These include possible antagonistic effects against lymphocyte senescence, through telomerase activation, and a potentiating activity on the production of IFN-gamma following T cell activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11589480     DOI: 10.1179/joc.2001.13.4.384

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  1 in total

1.  The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro.

Authors:  Riccardo Adamo; Alessandro Comandini; Angelo Aquino; Laura Bonmassar; Loredana Guglielmi; Enzo Bonmassar; Ornella Franzese
Journal:  J Exp Clin Cancer Res       Date:  2013-06-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.